What is the treatment for a suspected acetaminophen (Tylenol) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acetaminophen (Tylenol) Overdose

Administer N-acetylcysteine (NAC) immediately to any patient with suspected acetaminophen overdose—do not wait for laboratory confirmation if the ingestion occurred within 24 hours, as treatment within 8 hours prevents severe hepatotoxicity in 97% of cases. 1

Immediate Actions (Do Not Delay)

Step 1: Stabilize and Decontaminate

  • Give activated charcoal 1 g/kg orally within 4 hours of ingestion if the patient can protect their airway, administered just prior to starting NAC 1, 2
  • Draw blood immediately for: acetaminophen level, AST, ALT, INR, creatinine, BUN, electrolytes, and glucose 3, 2
  • Start NAC immediately without waiting for lab results if ingestion occurred within 24 hours 1, 2

Step 2: Initiate NAC Treatment

IV Protocol (Preferred): 1

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes
  • Second dose: 50 mg/kg over 4 hours
  • Third dose: 100 mg/kg over 16 hours (total 21-hour protocol)

Oral Protocol (Alternative): 1, 2

  • Loading dose: 140 mg/kg diluted to 5% solution
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses (total 72 hours)
  • If vomiting occurs within 1 hour, repeat that dose 2

Risk Stratification Using the Rumack-Matthew Nomogram

The nomogram ONLY applies to: 4, 1

  • Single acute ingestions
  • Known time of ingestion
  • Acetaminophen level drawn 4-24 hours post-ingestion

Critical timing thresholds: 1

  • Levels drawn before 4 hours are unreliable—repeat at 4 hours
  • Treatment within 8 hours: 2.9% develop severe hepatotoxicity
  • Treatment within 10 hours: 6.1% develop severe hepatotoxicity
  • Treatment after 10 hours: 26.4% develop severe hepatotoxicity

If the acetaminophen level plots above the "possible toxicity" line, continue full NAC course. 4, 1 If below the line and drawn 4+ hours post-ingestion with normal liver enzymes, NAC can be discontinued. 1

Special Scenarios Requiring Modified Management

Extended-Release Acetaminophen

  • Obtain serial acetaminophen levels at 4 hours AND again 4-6 hours later (at 8-14 hours post-ingestion), as absorption continues beyond the typical 2-4 hour window 5, 1
  • Initiate NAC if either level is above the nomogram line 5
  • Three patients in one case series had initial levels below the treatment line but later rose above it 5

Repeated Supratherapeutic Ingestion (RSTI)

The nomogram does NOT apply—treat based on these criteria: 1, 6

  • ≥10 g or 200 mg/kg (whichever is less) in any 24-hour period, OR
  • ≥6 g or 150 mg/kg (whichever is less) per day for ≥48 hours, OR
  • Any detectable acetaminophen level with AST or ALT >50 IU/L

Delayed Presentation (>24 Hours Post-Ingestion)

The nomogram does NOT apply—treat immediately if: 1

  • Any detectable acetaminophen level, OR
  • AST/ALT elevated (especially >1,000 IU/L), OR
  • Clinical suspicion remains high

NAC still reduces mortality even when started late: from 80% to 52% in fulminant hepatic failure, regardless of time since ingestion 1

Chronic Alcoholics and High-Risk Patients

  • Treat even with acetaminophen levels in the "non-toxic" range on the nomogram 1, 6
  • Severe hepatotoxicity documented with doses as low as 4-5 g/day in chronic alcohol users 6
  • Consider maximum daily therapeutic dose of 2-3 g in these patients 6

Unknown Time of Ingestion

  • Treat with NAC if any detectable acetaminophen level 1
  • Base decisions on acetaminophen level plus liver function tests, not the nomogram 1

When to Continue or Stop NAC

Continue NAC Beyond Standard Protocol If: 1

  • Delayed presentation (>24 hours)
  • Extended-release formulation
  • Repeated supratherapeutic ingestion
  • Unknown time of ingestion with detectable levels
  • Any elevation in AST or ALT above normal
  • Rising transaminases
  • Any coagulopathy (elevated INR)

Safe to Discontinue NAC When: 1

  • Acetaminophen level undetectable, AND
  • AST and ALT completely normal, AND
  • INR normal, AND
  • Patient is not high-risk (no chronic alcohol use, known time of acute ingestion)

Monitor AST, ALT, and INR every 4 hours until aminotransferases peak and decline. 3

Critical Red Flags Requiring ICU and Transplant Consultation

Transfer to ICU and contact liver transplant center immediately if: 1

  • AST or ALT >1,000 IU/L (severe hepatotoxicity) 6
  • Any coagulopathy (elevated INR)
  • Encephalopathy
  • Acute renal failure 7
  • Metabolic acidosis

Very high aminotransferases (>3,500 IU/L) are highly specific for acetaminophen poisoning and should raise suspicion even without clear overdose history. 3

Common Pitfalls to Avoid

  1. Never wait for acetaminophen levels to start NAC if ingestion occurred within 24 hours 1, 2

  2. Do not rely on a single 4-hour level for extended-release formulations—obtain a second level 4-6 hours later 5

  3. Low or absent acetaminophen levels do NOT rule out toxicity if ingestion was remote, occurred over several days, or timing is uncertain 1

  4. The nomogram is useless for: repeated supratherapeutic ingestions, unknown time of ingestion, delayed presentations >24 hours, and extended-release formulations 1

  5. Do not stop NAC prematurely—if any doubt exists or transaminases are rising, continue treatment 1

  6. Activated charcoal may reduce NAC absorption—if charcoal was given, consider lavage before NAC or accept potentially reduced effectiveness 2

  7. Even therapeutic doses (4 g/day for 14 days) cause ALT elevations >3× normal in 31-41% of healthy adults—context matters when interpreting mildly elevated transaminases 6

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Testing in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tylenol Extended Relief overdose.

Annals of emergency medicine, 1997

Guideline

Acetaminophen Toxicity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute renal failure due to acetaminophen ingestion: a case report and review of the literature.

Journal of the American Society of Nephrology : JASN, 1995

Related Questions

What is the treatment for an acetaminophen (Tylenol) overdose?
What is the treatment for acetaminophen (Tylenol) ingestion toxicity?
How soon can you re-administer Tylenol (acetaminophen) after a patient vomits?
What are the physical and diagnostic findings associated with acetaminophen (N-acetyl-p-aminophenol) ingestion?
What is the best course of action for a patient with a history of daily alcohol consumption and smoking, who presented with seizures, high-grade fever, and an unarousable state, following a fall on the back during a drinking spree, and has developed urinary retention with a distended bladder and impaired renal function, despite being medicated with Paracetamol (acetaminophen) and Dexamethasone?
What are the pros and cons of using Nexletol (bempedoic acid), fenofibrate, and ezetimibe for cholesterol management in patients with mixed dyslipidemia, particularly those with a history of muscle-related side effects to statins (HMG-CoA reductase inhibitors) and/or impaired renal function?
What is the recommended titration schedule for fluoxetine (selective serotonin reuptake inhibitor) in patients with depression, considering potential interactions and impaired renal function?
What is the primary treatment for a patient with Factor 5 (coagulation factor V) deficiency?
What is the best management approach for a patient with uncontrolled diabetes, chronic kidney disease, hypokalemia, anemia, secondary hyperparathyroidism, and suspected infection?
What are the signs of critical ischemia of the lower limb in a patient with a history of peripheral arterial disease (PAD), diabetes, or other risk factors?
What is the management approach for a patient with Factor 5 deficiency, a rare bleeding disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.